November 8, 2012

A Food and Drug Administration expert panel has voted unanimously in favor of approval for a Novartis drug for a rare endocrine disorder.

February 23, 2012

The Food and Drug Administration has approved a drug for a rare disorder that previously had no approved medical therapies, the agency said.

September 21, 2010

Swiss drug maker Novartis said its investigational drug is the first to show promise in...